Ascletis Pharma Inc
HKEX:1672

Watchlist Manager
Ascletis Pharma Inc Logo
Ascletis Pharma Inc
HKEX:1672
Watchlist
Price: 1.51 HKD -4.43% Market Closed
Market Cap: 1.5B HKD
Have any thoughts about
Ascletis Pharma Inc?
Write Note

Ascletis Pharma Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ascletis Pharma Inc
Cash from Operating Activities Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Ascletis Pharma Inc
HKEX:1672
Cash from Operating Activities
-ÂĄ144.2m
CAGR 3-Years
-19%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Operating Activities
-ÂĄ7.8B
CAGR 3-Years
-15%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Operating Activities
ÂĄ1.5B
CAGR 3-Years
49%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Cash from Operating Activities
ÂĄ796.9m
CAGR 3-Years
-13%
CAGR 5-Years
9%
CAGR 10-Years
13%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Operating Activities
ÂĄ6.5B
CAGR 3-Years
-12%
CAGR 5-Years
54%
CAGR 10-Years
43%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Operating Activities
ÂĄ2B
CAGR 3-Years
66%
CAGR 5-Years
71%
CAGR 10-Years
N/A

See Also

What is Ascletis Pharma Inc's Cash from Operating Activities?
Cash from Operating Activities
-144.2m CNY

Based on the financial report for Dec 31, 2023, Ascletis Pharma Inc's Cash from Operating Activities amounts to -144.2m CNY.

What is Ascletis Pharma Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-8%

Over the last year, the Cash from Operating Activities growth was -1%. The average annual Cash from Operating Activities growth rates for Ascletis Pharma Inc have been -19% over the past three years , -8% over the past five years .

Back to Top